Hudson Bay Capital Management LP Uni Qure N.V. Put Options Transaction History
Hudson Bay Capital Management LP
- $25.7 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding QURE
# of Institutions
180Shares Held
52.4MCall Options Held
4.41MPut Options Held
1.23M-
Rtw Investments, LP New York, NY5.16MShares$73.8 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$57 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$52.9 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$51.8 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$39.3 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $668M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...